Validation and clinical application of the hereditary hemorrhagic telangiectasia-specific quality of life scale
Journal of Thrombosis and Haemostasis · 2026
DOI: 10.1016/j.jtha.2025.09.024 ↗Kurz gefasst
Validierungsstudie in der Zeitschrift Journal of Thrombosis and Haemostasis, 2026. Verfasst von Hanny Al-Samkari und 14 weiteren Autor:innen. Beteiligte Einrichtung: Division of Hematology Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA. Electronic address: hal-samkari@…. Hauptthemen laut MEDLINE: Quality of Life, Telangiectasia, Hereditary Hemorrhagic. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NHLBI NIH HHS, National Heart Lung and Blood Institute, Alnylam Pharmaceuticals.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Hematology Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA. Electronic address: hal-samkari@mgh.harvard.edu.
- Division of Hematology/Oncology, University of North Carolina, Chapel Hill, North Carolina, USA.
- Division of Pulmonary/Critical Care, Mayo Clinic, Rochester, Minnesota, USA.
- Division of Hematology/Oncology, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
- Department of Internal Medicine, Medical College of Wisconsin, Milwaukee, Wisconsin, USA.
- Department of Radiology, Johns Hopkins University, Baltimore, Maryland, USA.
Förderung
- NHLBI NIH HHS
- National Heart Lung and Blood Institute
- Alnylam Pharmaceuticals
- U.S. Department of Defense
- Health Resources and Services Administration
Zitieren
APA
Al-Samkari, H., Kasthuri, R. S., Iyer, V. N., Pishko, A. M., Decker, J. E., Weiss, C. R., Whitehead, K. J., Conrad, M. B., Zumberg, M. S., Zhou, J. Y., Parambil, J., Carper, B., Clancy, M., Thomas, S. M., & McCrae, K. R. (2026). Validation and clinical application of the hereditary hemorrhagic telangiectasia-specific quality of life scale. Journal of Thrombosis and Haemostasis. https://doi.org/10.1016/j.jtha.2025.09.024
Vancouver
Al-Samkari H, Kasthuri RS, Iyer VN, Pishko AM, Decker JE, Weiss CR, et al. Validation and clinical application of the hereditary hemorrhagic telangiectasia-specific quality of life scale. Journal of Thrombosis and Haemostasis. 2026. doi:10.1016/j.jtha.2025.09.024
BibTeX
@article{AlSamkari2026,
author = {Al-Samkari, Hanny and Kasthuri, Raj S and Iyer, Vivek N and Pishko, Allyson M and Decker, Jake E and Weiss, Clifford R and Whitehead, Kevin J and Conrad, Miles B and Zumberg, Marc S and Zhou, Jenny Y and Parambil, Joseph and Carper, Benjamin and Clancy, Marianne and Thomas, Sonia M and McCrae, Keith R},
title = {Validation and clinical application of the hereditary hemorrhagic telangiectasia-specific quality of life scale},
journal = {Journal of Thrombosis and Haemostasis},
year = {2026},
doi = {10.1016/j.jtha.2025.09.024}
}
EUVIMED